Please note that effective as of 1 August 2017 Alfa Wassermann S.p.A., Biofutura Pharma S.p.A. and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (collectively, the “Merged Companies”) merged into Alfasigma S.p.A. ( “Alfasigma”), with Alfasigma being the surviving entity of the merger. Alfasigma will automatically succeed by operation of law to all rights and obligations of the Merged Companies. This web page will remain active until all the activities of the process relating to the transfer to Alfasigma of the drugs title to the marketing authorizations, selling licenses previously owned and the other products previously distributed by Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., are completed.
Please further note that pursuant to the applicable law on personal data protection, including the order of the Privacy Authority
dated 8 April 2009 on “Rules Applicable to Mergers & Acquisitions” (published in the Official Gazette No.
106 of 9 May 2009), the privacy statement previously released by the Merged Companies pursuant to article 13
of Legislative Decree no. 196/2003 is updated effective from 1 August 2017 as follows:
- the new Data Controller is: Alfasigma S.p.A., with registered address at Viale Sarca, 223 - 20126 Milan (Italy)
and administrative offices at Via Ragazzi del ’99, 5 - 40133 Bologna (Italy) - VAT number 03432221202;
- the new contact for exercising the rights provided for in articles 7 et seq. of the Privacy Code is:
All personal data will continue to be processed in accordance with the applicable law, the given consent (to the
extent applicable), and the current contractual relationships.
An updated list of the Data Processors may be requested in writing to the Privacy Department at: